Información:
Error:
ID
29825
Descripción
A Trial l of Panobinostat Given in Combination With Trastuzumab and Paclitaxel in Adult Female Patients With HER2 Positive Metastatic Breast Cancer; ODM derived from: https://clinicaltrials.gov/show/NCT00788931
Link
https://clinicaltrials.gov/show/NCT00788931
Palabras clave
Versiones (1)
- 22/4/18 22/4/18 -
Titular de derechos de autor
See clinicaltrials.gov
Subido en
22 de abril de 2018
DOI
Para solicitar uno, por favor iniciar sesión.
Licencia
Creative Commons BY 4.0
Comentarios del modelo :
Puede comentar sobre el modelo de datos aquí. A través de las burbujas de diálogo en los grupos de elementos y elementos, puede agregar comentarios específicos.
Comentarios de grupo de elementos para :
Comentarios del elemento para :
Para descargar modelos de datos, debe haber iniciado sesión. Por favor iniciar sesión o Registrate gratis.
Eligibility HER-2 Positive Breast Cancer NCT00788931
Eligibility HER-2 Positive Breast Cancer NCT00788931
- StudyEvent: Eligibility
Similar models
Eligibility HER-2 Positive Breast Cancer NCT00788931
- StudyEvent: Eligibility
Name
Tipo
Description | Question | Decode (Coded Value)
Tipo de datos
Alias
Age
Item
age > 18 year old
boolean
C0001779 (UMLS CUI [1])
Secondary malignant neoplasm of female breast HER2/Neu Positive
Item
confirmed her2+ metastatic breast cancer
boolean
C0346993 (UMLS CUI [1,1])
C2348909 (UMLS CUI [1,2])
C2348909 (UMLS CUI [1,2])
Trastuzumab | Disease Progression
Item
prior treatment and progression on trastuzumab
boolean
C0728747 (UMLS CUI [1])
C0242656 (UMLS CUI [2])
C0242656 (UMLS CUI [2])
Organ function
Item
patients must have adequate organ functions
boolean
C0678852 (UMLS CUI [1])
ECOG performance status
Item
eastern cooperative oncology group (ecog) performance status of ≤ 1
boolean
C1520224 (UMLS CUI [1])
Operative Surgical Procedures
Item
patients who have had surgery within last 2 weeks prior to starting the treatment
boolean
C0543467 (UMLS CUI [1])
Therapeutic procedure Metastatic malignant neoplasm to brain
Item
patients who receive concurrent therapy for brain metastases
boolean
C0087111 (UMLS CUI [1,1])
C0220650 (UMLS CUI [1,2])
C0220650 (UMLS CUI [1,2])
Decreased cardiac function | Heart Disease
Item
impaired heart function or clinically significant heart disease
boolean
C0232166 (UMLS CUI [1])
C0018799 (UMLS CUI [2])
C0018799 (UMLS CUI [2])
Diarrhea
Item
ongoing diarrhea
boolean
C0011991 (UMLS CUI [1])
Liver diseases | Kidney Diseases | Liver Dysfunction | Renal Insufficiency
Item
liver or renal disease with impaired hepatic or renal functions
boolean
C0023895 (UMLS CUI [1])
C0022658 (UMLS CUI [2])
C0086565 (UMLS CUI [3])
C1565489 (UMLS CUI [4])
C0022658 (UMLS CUI [2])
C0086565 (UMLS CUI [3])
C1565489 (UMLS CUI [4])
Cancer treatment | Antineoplastic Agents
Item
concomitant use of any anti-cancer therapy or certain drugs
boolean
C0920425 (UMLS CUI [1])
C0003392 (UMLS CUI [2])
C0003392 (UMLS CUI [2])
Pregnancy | Breast Feeding
Item
female patients who are pregnant or breast feeding
boolean
C0032961 (UMLS CUI [1])
C0006147 (UMLS CUI [2])
C0006147 (UMLS CUI [2])
Contraceptive methods Unwilling | Clinical Trial Eligibility Criteria Study Protocol
Item
patients not willing to use an effective method of birth control other protocol-defined inclusion/exclusion criteria may apply
boolean
C0700589 (UMLS CUI [1,1])
C0558080 (UMLS CUI [1,2])
C1516637 (UMLS CUI [2,1])
C2348563 (UMLS CUI [2,2])
C0558080 (UMLS CUI [1,2])
C1516637 (UMLS CUI [2,1])
C2348563 (UMLS CUI [2,2])